Data Pulse: A Five-Time Increase in Use of Medisafe for Obesity Meds

A $260.6B Challenge: How Patients Manage Obesity Meds

Weight Management affects 650M people worldwide. Four million people die each year as a result of obesity, according to the World Health Organization [1], making it a serious global problem. Annual obesity-related medical care costs in the United States, were estimated to be $260.6B.
In the last 5 years, the popularity of medications that Medisafe users took for obesity has doubled. That jump was propelled mostly by Semaglutide medications: Wegovy and Ozempic. These meds had not substituted for types of anti-obesity meds – rather they added new patients to the population of users taking meds for weight control.

Click here to see what they are saying about it: Weight Management_Data_Pulse Report

You may also like

Webinar Recording: Doing Digital Right – What Patients Really Want from Pharma

Patients are feeling empowered by digital health solutions, and a survey by Medisafe shows that Pfizer, Abbott, Astra Zeneca, and 

..Read More

New Analysis Shows Reduction in Annual Patient Costs and Medical Claims with Medisafe

BOSTON – Medisafe, a leading digital health company specializing in medication engagement, released the results of a new retrospective, pre- 

..Read More
Case Studies

Medisafe Discovers Mismanagement of Leading Asthma Medication

Medisafe data shows that more than 25% of patients who take a leading asthma medication do so in the morning. 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.